Metraipolis › archive › dc_bf4f43ac47fe
In vitro and clinical data demonstrate negligible risk of drug-drug interactions with opelconazole, a novel inhaled antifungal agent — Europe PMC PMID:41105437
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41105437
- DOI
- 10.1093/jac/dkaf384
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T03:32:52.938Z
- SHA-256 of the archived text
3b9060e9a9413f5078072bbef5c150eb94d2b9d5743c3460f25da34d2edc02b6- Stable URL of this page
https://metraipolis.com/documento/dc_bf4f43ac47fe
How to cite
In vitro and clinical data demonstrate negligible risk of drug-drug interactions with opelconazole, a novel inhaled antifungal agent — Europe PMC PMID:41105437 — Europe PMC (en), https://europepmc.org/article/MED/41105437 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf4f43ac47fe (Metraipolis archive dc_bf4f43ac47fe, sha256 3b9060e9a9413f5078072bbef5c150eb94d2b9d5743c3460f25da34d2edc02b6)
BibTeX
@misc{dcbf4f43ac47fe,
title = {In vitro and clinical data demonstrate negligible risk of drug-drug interactions with opelconazole, a novel inhaled antifungal agent — Europe PMC PMID:41105437},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41105437},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf4f43ac47fe; sha256 3b9060e9a9413f5078072bbef5c150eb94d2b9d5743c3460f25da34d2edc02b6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41105437. Agents can read the archived copy with the MCP tool read_document.